Target intelligence / Profile preview

Zinc-finger DNA binding protein (ZNF)

Target
ZNF
Molecular classification
Transcription factor, DNA-binding protein, Other, Enzyme
01

Overview

Zinc-finger DNA binding proteins contain structural motifs called zinc fingers, typically stabilized by the coordination of zinc ions with cysteine and histidine residues. The classical C2H2 zinc finger motif is the most common DNA-binding domain in eukaryotic transcription factors. These proteins bind DNA, often in a sequence-specific manner, and regulate gene expression, chromatin structure, and many other cellular processes. The protein family is highly versatile—members can also bind RNA, other proteins, and lipids, influencing cell cycle, apoptosis, differentiation, and stress responses. Dysregulation of zinc-finger DNA binding proteins is implicated in diverse diseases, prominently cancer, and their domains form the basis of therapeutically important gene editing tools such as zinc finger nucleases.

Other names
Zinc finger proteinZNFC2H2 zinc finger proteinDNA-binding zinc finger proteinzinc finger transcription factor
02

Mechanism of action

Gene editing via engineered zinc finger nucleases (ZFNs): targeted DNA cleavage for mutagenesis or gene correction Modulation of transcription factor activity (regulating gene expression at the DNA level)

03

Biological functions

Transcriptional regulationDNA recognition and bindingCell adhesionProtein degradationSignal transductionDNA repairChromatin remodelingApoptosis regulationCell migration
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationInfectionOther
05

Safety considerations

Off-target effects in genome editing (ZFNs)Broad transcriptional impacts due to pleiotropic roles (may lead to toxicity or unwanted gene expression changes)Some ZNFs have dual roles in tumorigenesis and normal cell functions, complicating drug targeting
06

Interacting drugs

No small molecules directly targeting most DNA-binding ZNFs are in clinical use; genome editing technologies (e.g., zinc finger nucleases) interact with ZNFs for gene therapy purposes

1 more in the full profile.

07

Biomarkers

ZNF expression levels serve as prognostic or predictive biomarkers in several cancers (e.g., ZNF217 overexpression predicts poor prognosis in breast, ovarian and colorectal cancers)ZNF mutations can be diagnostic in genetic syndromes

Beyond the preview

Go deeper on Zinc-finger DNA binding protein (ZNF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-finger DNA binding protein (ZNF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call